StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Oxazolam

HCID 4617
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
24143-17-7
Standard-SMILES
CC1CN2CC(=O)Nc3ccc(Cl)cc3C2(c2ccccc2)O1
InChIKey
VCCZBYPHZRWKFY-UHFFFAOYSA-N
Summenformel
C18H17ClN2O2
Durchschnittliche Molmasse
328,8 g/mol
Monoisotopische Masse
328,0978555

Überblick

Oxazolam is a hemiaminal ether and an organic molecular entity.

Namen und Bezeichner

Bevorzugter Name
Oxazolam
IUPAC
10-chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
Lokaler Name
Oxazolam
Englischer Name
OXAZOLAM METHANOL SOLUTION
Summenformel
C18H17ClN2O2
Molmasse
328.79

Namen und Synonyme

oxazolamOxazolazepamTranquitHializan24143-17-7Oxazolamum1V2WI2NA1CDTXSID502340110-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro(1,3)oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one10-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-oneRefChem:857082DTXCID80209312
Weitere Namen anzeigen
NebusnToccataSerenal (Japanese)o-2-methyl-11b-phenyl-OXAZOLAM METHANOL SOLUTION
10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenylbenzo(6,7)(1,4)diazepino(5,4-b) oxazol-6-one13-chloro-4-methyl-2-phenyl-3-oxa-6,9-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),11,13-trien-8-one246-032-0SerenalSerenal [Japanese]10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-oneBenzo(6,7)-1,4-diazepino-(5,4-b)-oxazol-6-one, 10-chloro-2,3,5,6,7,11b-hexahydro-2-methyl-11b-phenyl-

Datenbank-Bezeichner

CAS
24143-17-7
PubChem CID
4617
DTXSID
DTXSID5023401
ChEMBL
CHEMBL2104805
ChEBI
CHEBI:31944
UNII
1V2WI2NA1C
EC Number
246-032-0
Nikkaji
J3.472J

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
3
Polarare Oberfläche (TPSA)
41,6 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
1
Schwere Atome
23
Formalladung
0
Komplexität
468

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Physikochemische Eigenschaften

Schmelzpunkt
187 °C · 187°C
Siedepunkt
495.8 · 495.8±45.0 °C(Predicted)
Dichte
1.2065 · 1.2065 (rough estimate)
Brechungsindex
1.54 · 1.5400 (estimate)
Flammpunkt
11 °C · 11 °C
storage temp.
2 · 2-8°C
Löslichkeit
Chloroform (Slightly), Methanol (Slightly)
pka
12.85 · 12.85±0.60(Predicted)
Aggregatzustand
A solid

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationDEA schedule IV controlled substance
Hazard Classes and CategoriesAcute Tox. 3 (100%)

Toxikologische Informationen

Treatment · 1 Eintrag

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Chemie und Industrie

Anwendungen

VerwendenA psychotropic agent with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a precursor to the active substance Desmethyldiazepam (D291595).

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

5-CHLORO-2-CHLOROACETYLAMINOBENZOPHENONE(S)-(+)-1-Aminopropan-2-ol

Zugehörige Reaktionen

7
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 328480
HRID 328480als Produktuspto-grants-1977_04
Reaktionsgleichung von HRID 328492
HRID 328492als Produktuspto-grants-1977_04
Reaktionsgleichung von HRID 597626
HRID 597626als Produktuspto-grants-1977_03
Reaktionsgleichung von HRID 1658603
HRID 1658603als Produktuspto-grants-1976_06
Reaktionsgleichung von HRID 1973526
HRID 1973526als Produktuspto-grants-1976_12
Reaktionsgleichung von HRID 2071945
HRID 2071945als Produktuspto-grants-1977_09
Reaktionsgleichung von HRID 2071959
HRID 2071959als Produktuspto-grants-1977_09

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen
Toxicity Summary · 1 Eintrag

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Sicherheitsdaten

risk_code
11-23/24/25-39/23/24/25-36/38-23/25
Toxizität
LD50 orl-mus: 5200 mg/kg NYKZAU 66,107,70
hazard_code
F,T
safety_code
16-36/37-45-24
DEA Controlled Substances
CSCN: 2839CSA SCH: Schedule IVNARC: No